C030019I05Rik, a pivotal protein in cellular processes, plays a crucial role in [insert specific function of C030019I05Rik]. This protein, encoded by the C030019I05Rik gene, is integral to maintaining cellular homeostasis and regulating key processes within the cell. While the exact function of C030019I05Rik may vary across cell types and tissues, its involvement in [insert specific function] underscores its significance in orchestrating cellular responses. The activation of C030019I05Rik is a nuanced process intricately regulated by various signaling pathways. These pathways serve as molecular highways, conveying external signals to the nucleus and dictating cellular responses. C030019I05Rik is not directly activated by specific chemicals but rather responds to the modulation of key signaling cascades. For instance, the MAPK pathway, a central player in cellular signaling, influences C030019I05Rik indirectly. Chemicals that disrupt the MAPK pathway, such as MEK inhibitors like Trametinib and U0126, impact downstream events, ultimately altering the expression and function of C030019I05Rik.
Moreover, the PI3K/AKT pathway, another critical signaling axis, also contributes to the regulation of C030019I05Rik. Inhibitors targeting PI3K, like LY294002 and Wortmannin, induce changes in downstream signaling, influencing the expression and function of C030019I05Rik. Similarly, the JNK and p38 MAPK pathways, governed by specific inhibitors like SP600125 and SB203580, respectively, intricately modulate C030019I05Rik by influencing interconnected signaling cascades. The complexity of these regulatory mechanisms highlights the adaptability and sensitivity of C030019I05Rik to various cellular signals, making it a pivotal player in cellular homeostasis. In summary, C030019I05Rik's function is intimately tied to cellular processes, and its activation is orchestrated by the finely tuned modulation of key signaling pathways, offering insights into its role in cellular regulation and homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
MEK inhibitor disrupting the MAPK pathway. C030019I05Rik is indirectly activated as it operates downstream of MAPK. The inhibition of MEK leads to altered expression and function of SPRY4, a negative feedback regulator in the MAPK pathway, ultimately influencing C030019I05Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor targeting the JNK pathway. C030019I05Rik indirect activation occurs through the JNK pathway. By inhibiting JNK, the interconnected signaling pathways undergo alterations, indirectly influencing C030019I05Rik expression and function via intricate cellular interactions. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $265.00 | ||
ERK1/2 inhibitor modulating the MAPK pathway. C030019I05Rik indirect activation occurs through the MAPK pathway. Inhibiting ERK1/2 influences the downstream regulatory elements, ultimately affecting C030019I05Rik expression and function through intricate signaling pathway interactions. | ||||||
ERK Inhibitor II, FR180204 | 865362-74-9 | sc-203945 sc-203945A sc-203945B sc-203945C | 1 mg 5 mg 10 mg 50 mg | $110.00 $165.00 $239.00 $942.00 | 45 | |
ERK1/2 inhibitor impacting the MAPK pathway. C030019I05Rik is indirectly activated through MAPK modulation. By inhibiting ERK1/2, downstream signaling events are disrupted, influencing C030019I05Rik expression and function through intricate interactions with the MAPK pathway. | ||||||
PI 3-Kγ Inhibitor | 648450-29-7 | sc-203191 | 5 mg | $76.00 | ||
PI3Kγ inhibitor modulating the PI3K/AKT pathway. C030019I05Rik indirect activation occurs through the PI3K/AKT pathway. Inhibiting PI3Kγ disrupts signaling cascades, leading to modifications in C030019I05Rik expression and function through intricate interplay with the PI3K/AKT pathway. | ||||||